Last updated on September 2020

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus


Brief description of study

The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes.

Clinical Study Identifier: NCT04450394

Find a site near you

Start Over

Diablo Clinical Research

Walnut Creek, CA United States
4.67miles
  Connect »

Diablo Clinical Research, Inc.

Walnut Creek, CA United States
4.67miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.